18F-fluoro-2-deoxy-glucose uptake predicts clinical outcome in patients with gefitinib-treated non-small cell lung cancer.

@article{Na200818Ffluoro2deoxyglucoseUP,
  title={18F-fluoro-2-deoxy-glucose uptake predicts clinical outcome in patients with gefitinib-treated non-small cell lung cancer.},
  author={Im Il Na and Byung Hyun Byun and Hye Jin Kang and Gi Jeong Cheon and Jae Soo Koh and Cheol Hyeon Kim and Du Hwan Choe and B Ryoo and Jae Cheol Lee and Sang Moo Lim and Sung Hyun Yang},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2008},
  volume={14 7},
  pages={2036-41}
}
PURPOSE To evaluate response and survival according to (18)F-fluoro-2-deoxy-glucose uptake at presentation in patients with gefitinib-treated non-small cell lung cancer. EXPERIMENTAL DESIGN We retrospectively analyzed 84 positron emission tomography/computed tomography findings. Patient characteristics, response rates, and survivals were evaluated according to the maximum standardized uptake value (SUV) of primary tumor. The cutoff value of SUVs was obtained from receiver operating… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Similar Papers

Loading similar papers…